• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

lawyer

  1. IDEXX REPS AND THEIR CAR ACCIDENTS

    IDEXX reps continue to be terrorized by having to choose between driving safely and meeting with a ridiculous amount of customers each week (or lying in salesforce and writing that you have seen more customers than you actually have). last week at sales meeting reps were comparing notes again...